Nation's highest court declined to review a NJ Supreme Court decision adressing informed consent for abortion procedures.
The nation's highest court declined to review a New Jersey Supreme Court decision that addressed informed consent for abortion procedures, according to American Medical News (11/17/08).
The case began in 1998 after Rosa Acuna underwent an abortion at the advice of her physician, Dr. Sheldon C. Turkish, because the pregnancy was damaging her kidneys. Following the abortion, Ms. Acuna sued Dr. Turkish for malpractice, alleging that he failed to inform her that at the time of the abortion the embryo was a "complete, separate, unique and irreplaceable human being" and claiming that this failure had resulted in severe emotional and psychological trauma. The trial court dismissed the case, citing the US Supreme Court ruling that "a fetus is not a person," but an appellate court decided that Ms. Acuna could sue her ob/gyn for damages relating to "a question of medical malpractice."
The New Jersey Supreme Court dismissed the medical malpractice lawsuit in September 2007, however, finding that state law does not require a physician to tell a woman seeking an abortion that the procedure would result in terminating the life of a living human being. The court said that while doctors have a duty to tell patients about an abortion's medical risks, they do not have to discuss moral, religious, or philosophic judgments that lack broad support from the medical and scientific community.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More